SLC7A11 and neoplasm: Recently, a growing number of studies have highlighted the role of Slc7a11 overexpression in partially promoting tumor growth by inhibiting ferroptosis, suggesting that Slc7a11 exhibited antiferroptosis function during malignant progression (34–36).